LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
34 funds hold it · Insiders net selling
Net selling: insiders sold $40.8M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 29, 2026
Financial period
Third Quarter 2026
Earnings per share
$4.68 expected
Revenue
$5.51B expected
FY 2026 guidance
$22.05B to $22.45B
No comparable estimate
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 29, 2026 | $6.64est. $4.68 | +42.01%beat | $5.63Best. $5.51B+2.16% | +6.5%from $5.29B |
| Jun 30, 2026Reported Jul 23, 2026 | $6.12est. $4.26 | +43.54%beat | $5.63BSEC filing | +6.8%from $5.27B |
| Mar 31, 2026Reported Apr 30, 2026 | $4.82est. $4.17 | +15.73%beat | $5.37BSEC filing | +2.8%from $5.22B |
| Dec 31, 2025Reported Feb 11, 2026 | $4.70est. $4.07 | +15.62%beat | $5.53BAlpha Vantage | +9.0%from $5.07B |
| Sep 30, 2025Reported Oct 28, 2025 | $3.70est. $3.35 | +10.45%beat | $5.29BSEC filing | +3.2%from $5.13B |
| Jun 30, 2025Reported Jul 22, 2025 | $4.02est. $2.87 | +40.07%beat | $5.27BSEC filing | +3.2%from $5.11B |
| Mar 31, 2025Reported Apr 29, 2025 | $4.36est. $3.13 | +39.30%beat | $5.22BSEC filing | -2.7%from $5.37B |
| Dec 31, 2024Reported Feb 12, 2025 | $3.44est. $2.83 | +21.45%beat | $5.07BAlpha Vantage | -5.7%from $5.38B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.53B | $5.37B | $5.63B | $6.28B |
| Cost of what it sold | $4.66B | $4.49B | $4.60B | $2.35B |
| Gross profit | $869.0M | $882.0M | $1.02B | $3.92B |
| What it spent | ||||
| Sales and admin | $2.22B | $2.17B | $2.23B | $2.17B |
| Other operating costs | -$780.0M | $2.31B | $2.37B | — |
| Total operating expenses | $1.44B | $4.49B | $4.60B | $2.17B |
| What was left | ||||
| Operating profit | $869.0M | $882.0M | $1.02B | $1.75B |
| Interest on debt | $205.0M | $205.0M | $204.0M | $203.0M |
| Profit before tax | $681.0M | $1.13B | $1.34B | $1.58B |
| Tax | $37.0M | $226.0M | $295.0M | $360.0M |
| Net profit | $371.0M | $702.0M | $826.0M | $1.00B |
| EBITDA | $1.12B | $1.57B | $1.24B | $2.00B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Tenet Healthcare (THC) Is Back In Focus, What Is The Market Weighing?
NeutralNov 11Learn Why The Bull Case For Tenet Healthcare Stock Could Change Following Raised 2026 Guidance
Leans bullishNov 8What Tenet Healthcare Holders Got Right
BullishNov 7What Tenet Healthcare Bulls Got Right
BullishNov 6Tenet Healthcare (THC) Stock Looks Below Fair Value On Current Earnings
Leans bullishNov 6Tenet Healthcare Corporation (THC) Stock Forecasts
Leans bullishNov 5Universal Health Services, Tenet Healthcare, Moderna, Novavax, and Intuitive Surgical stocks trade up, what you need to know
BullishNov 4Tenet Healthcare Corporation (THC) Stock Forecasts
NeutralNov 435 macro signals shaping THC right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
